Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QMS Medical Allied ServicesNSE:QMSMEDI -1.11%77 EBITDA Margin % is 13.47% as of Mar. 2026, which is 3% below its 10-year median of 13.89. GuruFocus rates NSE:QMSMEDI with a GF Score™ of 77/100 and a GF Value™ of ₹120.61 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 815 Medical Devices & Instruments companies, QMS Medical Allied Services ranks better than 66.99% on this metric.
QMS Medical Allied Services (NSE:QMSMEDI) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
QMS Medical Allied Services EBITDA Margin % Related Terms
QMS Medical Allied Services EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:QMSMEDI vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, QMS Medical Allied Services's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QMS Medical Allied Services EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, QMS Medical Allied Services's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where QMS Medical Allied Services's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
QMS Medical Allied Services (NSE:QMSMEDI) has a EBITDA Margin % of 13.47% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on QMS Medical Allied Services and its competitors. This is near median its historical median of 13.89. Over the past decade, QMS Medical Allied Services' EBITDA Margin % has ranged from 11.32 to 17.39. According to the industry distribution chart, QMS Medical Allied Services ranks #269 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 33%.
Is QMS Medical Allied Services' EBITDA Margin % too high?
QMS Medical Allied Services' current EBITDA Margin % of 13.47% is near median its 10-year median of 13.89. Over the past 10 years, this metric has ranged from a low of 11.32 to a high of 17.39. The Medical Devices & Instruments industry median EBITDA Margin % is 7.47. QMS Medical Allied Services' value of 13.47% is 80.3% above this industry median. Based on the distribution chart, QMS Medical Allied Services ranks #269 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, QMS Medical Allied Services has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does QMS Medical Allied Services' EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, QMS Medical Allied Services ranks #269 out of 815 companies for EBITDA Margin %. This puts QMS Medical Allied Services in the upper half of its industry. The industry median EBITDA Margin % is 7.47. QMS Medical Allied Services' value of 13.47% is 80.3% above this benchmark. Historically, QMS Medical Allied Services' own EBITDA Margin % has ranged from 11.32 to 17.39 over the past decade. While the company's 10-year median is 13.89 vs. the industry median of 7.47, QMS Medical Allied Services has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.47, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. QMS Medical Allied Services's current EBITDA Margin % of 13.47% is 80.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on QMS Medical Allied Services and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QMS Medical Allied Services's current EBITDA Margin % is 13.47%, which is near median its own 10-year median of 13.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QMS Medical Allied Services stock overvalued right now?
Based on GuruFocus' analysis, QMS Medical Allied Services (NSE:QMSMEDI) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹120.61, compared to a current price of ₹106.96 — trading 11.3% below its estimated fair value. The current EBITDA Margin % is 13.47%, which is near median its 10-year median of 13.89 and 80.3% above the Medical Devices & Instruments industry median of 7.47. QMS Medical Allied Services' overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For QMS Medical Allied Services (NSE:QMSMEDI), the current EBITDA Margin % is 13.47% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is QMS Medical Allied Services (NSE:QMSMEDI) Overvalued in 2026?
Based on GuruFocus' analysis, QMS Medical Allied Services stock appears to be undervalued.
The current stock price of ₹106.96 is trading 11.3% below its estimated GF Value™ of ₹120.61.
GuruFocus considers QMS Medical Allied Services to be Modestly Undervalued.
Key valuation signals for NSE:QMSMEDI:
EBITDA Margin %: 13.47% (near median its 10-year median of 13.89)
GF Value™: ₹120.61 vs. price of ₹106.96 (11.3% below fair value)
Industry Position: 80.3% above the Medical Devices & Instruments median (#269 of 815)
No single metric tells the full story. See the NSE:QMSMEDI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
QMS Medical Allied Services Ltd is engaged in the marketing and distribution of a wide range of medical products as well as medical education services. The company's products are sold under brand name "QDevices" and also manage the distribution for other brands such as 3M, Heine, Rossmax and others. It offers medical products such as Blood Pressure Monitors, Glucose Monitoring Kits and strips, Dental Products, Personal protection kits eg-PPE kits, Infection prevention, Stethoscope and Oxygen Concentrator.
77GF Score
Get the complete analysis for NSE:QMSMEDI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QMSMEDI has been successfully added to your 
